Broder C C, Lottenberg R, Boyle M D
Department of Immunology, College of Medicine, University of Florida, Gainesville 32610.
Infect Immun. 1989 Sep;57(9):2597-605. doi: 10.1128/iai.57.9.2597-2605.1989.
A high-affinity surface receptor for human plasmin has been reported on certain group A streptococci. To map the region of the plasmin molecule that binds to the bacterial receptor, isolated domains of plasmin were tested for their ability to inhibit the binding of intact radiolabeled plasmin to receptor-positive bacteria. Complete inhibition of binding of labeled plasmin to bacteria by isolated heavy chains was achieved, but this inhibition was not as efficient on a molar basis when compared with that of unlabeled plasmin. By contrast, a conformationally altered form of native plasminogen was found to bind to bacteria and was as efficient a competitive inhibitor as intact plasmin was. The results of this study indicate that the selective binding of human plasmin to a group A streptococcus is dependent on structures present in the conformationally altered form of native plasminogen or plasmin that are not found on the native zymogen, the plasminogen with NH2-terminal glutamic acid.
据报道,在某些A组链球菌上存在一种人纤溶酶的高亲和力表面受体。为了确定纤溶酶分子中与细菌受体结合的区域,对分离出的纤溶酶结构域进行了测试,以检测其抑制完整放射性标记纤溶酶与受体阳性细菌结合的能力。分离出的重链可完全抑制标记纤溶酶与细菌的结合,但与未标记的纤溶酶相比,这种抑制在摩尔基础上效率不高。相比之下,发现天然纤溶酶原的一种构象改变形式可与细菌结合,并且是与完整纤溶酶一样有效的竞争性抑制剂。本研究结果表明,人纤溶酶与A组链球菌的选择性结合取决于天然纤溶酶原或纤溶酶构象改变形式中存在的结构,而这些结构在天然酶原(具有NH2末端谷氨酸的纤溶酶原)中不存在。